Status: Recruiting
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
The goal of this clinical trial is to collect additional data to demonstrate if the Contour Neurovascular System (CNS) is a safe and effective treatment of wide-necked, saccular, intracranial aneurysms. Participants will: Undergo treatment with the Contour Neurovascular System Complete follow-up visits at 1month, 12months, and 24 months, following their procedure Report any adverse events to their study team
Participants needed: 250
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Cerus Endovascular, Inc.Updated: Mar 31, 2026Locations: 9
Eligibility criteria
Patient is 18-75 years of age at the time of screening. [+11]
Anatomy or physiology considered unsuitable for endovascular treatment with the... [+16]